Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Disease; Flu”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01946425
What this trial is testing

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 60
Post-approval studies (Phase 4)Study completedNCT00993668
What this trial is testing

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 224
Early research (Phase 1)Looking for participantsNCT07526506
What this trial is testing

Study of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Traws Pharma, Inc. 32
Post-approval studies (Phase 4)Study completedNCT01249833
What this trial is testing

Effect of Oseltamivir on Cognitive Function in Subjects With Influenza

Who this might be right for
Influenza
Trial Management Group Inc. 122
Post-approval studies (Phase 4)Study completedNCT00258817
What this trial is testing

Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 30
Testing effectiveness (Phase 2)Study completedNCT05624606
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Testing effectiveness (Phase 2)Study completedNCT00439335
What this trial is testing

Higher Dose Intradermal H5 Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 227
Large-scale testing (Phase 3)Study completedNCT00996138
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Who this might be right for
Influenza
Novartis Vaccines 200
Not applicableEnded earlyNCT06274359
What this trial is testing

Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities

Who this might be right for
Influenza
Denver Health and Hospital Authority 398
Large-scale testing (Phase 3)Study completedNCT01001325
What this trial is testing

Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?

Who this might be right for
Influenza
Mount Sinai Hospital, Canada 468
Large-scale testing (Phase 3)Study completedNCT04381689
What this trial is testing

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Infants

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 260
Large-scale testing (Phase 3)Ended earlyNCT05513391
What this trial is testing

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 366
Testing effectiveness (Phase 2)Study completedNCT01419925
What this trial is testing

Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

Who this might be right for
InfluenzaHealthy
BiondVax Pharmaceuticals ltd. 120
Post-approval studies (Phase 4)Ended earlyNCT04141917
What this trial is testing

Test-and-treat for Influenza in Homeless Shelters

Who this might be right for
InfluenzaRespiratory Viral Infection
University of Washington 1,618
Not applicableStudy completedNCT05572450
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Who this might be right for
Influenza A H1N1
Hvivo 70
Testing effectiveness (Phase 2)Study completedNCT00374842
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07503405
What this trial is testing

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Who this might be right for
Influenza
Traws Pharma, Inc. 165
Post-approval studies (Phase 4)Study completedNCT04091880
What this trial is testing

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

Who this might be right for
Enterovirus InfectionsInfluenza
China National Biotec Group Company Limited 1,134
Large-scale testing (Phase 3)Study completedNCT00731029
What this trial is testing

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

Who this might be right for
Influenza
GlaxoSmithKline 239
Not applicableUnknownNCT02087761
What this trial is testing

A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients

Who this might be right for
Respiratory Tract InfectionBronchitisPneumonia
Luminex Corporation 1,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation